…
AlphaTON Capital Corp. operates as a digital asset treasury company. It focuses on building and managing a strategic reserve of The Open Network (TON) tokens and developing the Telegram ecosystem. The company provides public market investors with institutional-grade exposure to the TON ecosystem and Telegram's billion user platform. Its activities cover network validation and staking operations, and development of Telegram-based applications, as well as strategic investments in TON-based decentralized finance protocols, gaming platforms, and business applications. The company is also advancing various therapies that target known checkpoint resistance pathways to achieve durable treatment response and improve quality of life for patients. The company was formerly known as Portage Biotech Inc. and changed its name to AlphaTON Capital Corp. in September 2025. AlphaTON Capital Corp. is based in Road Town, British Virgin Islands.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Public information on AlphaTON Capital Corp. (NASDAQ: ATON) is limited, and its core business and strategy are not clearly disclosed in widely available filings. Because detailed drivers are not documented publicly, investors should review the company's regulatory filings to understand potential long-term growth sources. The stock may offer access to a listed investment vehicle but this requires confirmation of strategy, fees and manager track record.
Principal risks include limited transparency and disclosure, manager and execution risk, potential leverage and liquidity constraints, and governance issues common to externally managed investment vehicles.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Income before tax | -6.78M | -85.70M | -122.52M | -14.82M | -14.89M |
| Minority interest | 0.01M | 0.04M | 0.06M | 2.30M | - |
| Net income | -6.77M | -75.34M | -104.61M | -16.87M | -15.83M |
| Selling general administrative | 4.25M | 5.66M | 8.36M | 8.82M | 5.13M |
| Gross profit | -0.04M | -0.05M | -0.00M | - | - |
| Reconciled depreciation | 0.04M | 0.05M | 0.00M | 0.00M | - |
| Ebit | -6.78M | -18.25M | -122.25M | -30.30M | -26.43M |
| Ebitda | -6.74M | -18.20M | -122.25M | -14.77M | -14.71M |
| Depreciation and amortization | 0.04M | 0.05M | 0.00M | 15.59M | 12.24M |
| Operating income | -7.42M | -18.25M | -16.58M | -15.59M | -12.44M |
| Other operating expenses | 7.42M | 18.25M | 16.58M | 15.59M | 12.44M |
| Interest expense | 0.00M | 0.03M | 0.01M | 0.04M | 0.18M |
| Tax provision | -0.00M | -10.55M | -17.86M | 4.35M | - |
| Interest income | 0.09M | 0.27M | 0.22M | 0.00M | - |
| Net interest income | 0.09M | 0.24M | 0.21M | -0.04M | - |
| Income tax expense | -0.00M | -10.55M | -17.86M | 4.35M | 2.30M |
| Total revenue | 0.00M | 0.00M | 0.00M | 0.00M | - |
| Total operating expenses | 7.38M | 18.20M | 16.57M | 15.59M | 12.44M |
| Cost of revenue | 0.04M | 0.05M | 0.00M | - | - |
| Total other income expense net | 0.64M | -67.44M | -105.95M | 0.77M | -2.45M |
| Net income from continuing ops | -6.78M | -75.38M | -104.67M | -19.17M | - |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Total assets | 2.23M | 7.78M | 99.13M | 194.66M | 174.86M |
| Intangible assets | - | - | 81.68M | 117.39M | 117.39M |
| Other current assets | 0.54M | 2.63M | 2.45M | 1.27M | 1.49M |
| Total liab | 3.05M | 4.45M | 23.73M | 29.23M | 27.26M |
| Total stockholder equity | -0.12M | 4.02M | 76.05M | 121.20M | 101.45M |
| Other current liab | 0.67M | 2.36M | 1.59M | 0.59M | 2.94M |
| Common stock | 221.80M | 219.50M | 218.78M | 158.32M | 130.65M |
| Capital stock | 221.80M | 219.50M | 218.78M | 158.32M | - |
| Retained earnings | -245.45M | -239.32M | -159.62M | -55.01M | -38.13M |
| Good will | - | - | 0.00M | 43.32M | 43.32M |
| Cash | 1.67M | 5.03M | 10.54M | 23.35M | 2.77M |
| Total current liabilities | 1.10M | 2.88M | 1.86M | 0.78M | 3.21M |
| Net debt | -1.67M | -4.98M | -10.54M | -23.35M | -2.62M |
| Short term debt | - | 0.04M | - | - | 0.15M |
| Short long term debt total | - | 0.05M | - | - | 0.15M |
| Other stockholder equity | - | - | - | 16.93M | 7.98M |
| Total current assets | 2.23M | 7.70M | 13.68M | 24.83M | 4.95M |
| Long term investments | - | 0.00M | 2.89M | 9.08M | - |
| Net receivables | 0.01M | 0.04M | 0.68M | 0.21M | 0.68M |
| Accounts payable | 0.43M | 0.48M | 0.27M | 0.19M | 0.11M |
| Accumulated other comprehensive income | 23.53M | 23.84M | 16.88M | 0.96M | 0.96M |
| Non currrent assets other | - | 0.05M | 0.88M | 0.04M | 0.06M |
| Non current assets total | 0.00M | 0.08M | 85.45M | 169.83M | 169.91M |
| Capital lease obligations | 0.00M | 0.05M | 0.00M | - | - |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Investments | 0.00M | 2.81M | -0.62M | 0.00M | - |
| Total cashflows from investing activities | - | 2.81M | -0.62M | - | -0.86M |
| Net borrowings | -0.05M | -0.04M | -2.00M | 0.00M | - |
| Total cash from financing activities | 2.10M | 5.97M | -0.12M | 27.35M | 4.76M |
| Net income | -6.78M | -75.34M | -104.67M | -19.17M | -17.19M |
| Change in cash | -3.36M | -5.52M | -12.81M | 20.58M | -0.38M |
| Begin period cash flow | 5.03M | 10.54M | 23.35M | 2.77M | 3.15M |
| End period cash flow | 1.67M | 5.03M | 10.54M | 23.35M | 2.77M |
| Total cash from operating activities | -5.46M | -14.30M | -12.07M | -6.76M | -4.28M |
| Issuance of capital stock | 2.15M | 6.03M | 2.98M | 29.09M | - |
| Depreciation | 0.04M | 0.05M | 0.00M | 0.00M | 1.02M |
| Other cashflows from investing activities | - | - | -0.61M | - | -0.00M |
| Change to inventory | - | - | - | 1.21M | -0.88M |
| Change to account receivables | 1.57M | -0.03M | -0.03M | 0.52M | -0.11M |
| Other cashflows from financing activities | 0.00M | -0.02M | -1.10M | -1.75M | -1.25M |
| Capital expenditures | 0.00M | 0.00M | 0.00M | 0.00M | 1.00M |
| Change in working capital | 1.52M | 0.98M | -0.01M | -0.46M | -0.74M |
| Stock based compensation | 0.32M | 0.00M | 4.28M | 9.14M | 8.83M |
| Other non cash items | -0.56M | 70.57M | 106.21M | -0.67M | 1.36M |
| Free cash flow | -5.46M | -14.30M | -12.08M | -6.76M | -3.28M |
Sector: Financial Services Industry: Asset Management
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| BLK BlackRock Inc |
2.63 0.21% |
1228.94 | 26.25 | 19.57 | 6.33 | 2.90 | 6.35 | 17.13 |
| BX Blackstone Group Inc |
-1.80 1.48% |
120.20 | 33.20 | 20.12 | 11.05 | 11.56 | 9.14 | 15.74 |
| IVSBF Investor AB ser. B |
0.01 0.01% |
43.59 | 4.67 | 3.83 | 3.78 | 1.13 | 4.15 | 1.68 |
| KKR KKR & Co. Inc. |
-1.70 1.70% |
98.35 | 32.68 | 13.66 | 3.58 | 3.22 | 0.68 | 1.47 |
AlphaTON Capital Corp. operates as a digital asset treasury company. It focuses on building and managing a strategic reserve of The Open Network (TON) tokens and developing the Telegram ecosystem. The company provides public market investors with institutional-grade exposure to the TON ecosystem and Telegram's billion user platform. Its activities cover network validation and staking operations, and development of Telegram-based applications, as well as strategic investments in TON-based decentralized finance protocols, gaming platforms, and business applications. The company is also advancing various therapies that target known checkpoint resistance pathways to achieve durable treatment response and improve quality of life for patients. The company was formerly known as Portage Biotech Inc. and changed its name to AlphaTON Capital Corp. in September 2025. AlphaTON Capital Corp. is based in Road Town, British Virgin Islands.
Clarence Thomas Building, Road Town, British Virgin Islands, VG1110
302 219 5556
3
| Name | Title | Year Born |
|---|---|---|
| Dr. Robert A. Kramer Ph.D. | Chief Scientific Officer | 1952 |
| Mr. Fiorenzo A. Villani | Executive Chairman & Chief Investment Officer | 1971 |
| Ms. Brittany Kaiser | CEO & Director | 1989 |
| Mr. Wesley Allen Levitt C.F.A. | Chief Financial Officer | 1988 |
| Mr. Logan Ryan Golema | Chief Technology Officer | NA |
| Mr. William De'Ath | Chief Partnership Officer | NA |
| Adam Melero | Controller | NA |
| Mr. Peter Molloy | Chief Executive Officer of Cyncado Therapeutics Inc. | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.